《新股消息》滄港鐵路(02169.HK)今日起招股 入場費4,444.34元
內地貨運鐵路營運商滄港鐵路(02169.HK)公布招股詳情,計劃發售2.5億股股份,當中10%在港公開發售,招股價介乎0.85元至1.1元,每手4,000股,入場費為4,444.34元。由今日(12日)至本周四(15日)公開招股,預計於10月23日上市。創陞融資為獨家保薦人。
以招股價中位數0.975元計,公司預計集資淨額為1.99億元,當中63.3%用於建設兩條新的鐵路支線;20.2%用於技術升級、購買新機車及購買額外的設備;11.9%用於結算土地使用權的部分應付款項;3.1%用於償還銀行貸款;1.5%為營運資金及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.